Antipseudomonal activity of piperacillin/tazobactam: more than a decade of experience from the SENTRY Antimicrobial Surveillance Program (1997–2007)

RN Jones, MG Stilwell, PR Rhomberg… - … and infectious disease, 2009 - Elsevier
We evaluated the susceptibility rates for piperacillin/tazobactam tested against
Pseudomonas aeruginosa isolates from the Asia-Pacific (APAC), Europe (EU), Latin …
被引用次数：99 相关文章
[PDF] jmilabs.com

[PDF][PDF] Anti-Pseudomonal Activity of Piperacillin/tazobactam: More than a Decade of Experience from the SENTRY Antimicrobial Surveillance Program (1997-2007)

RN JONES, HS SADER, M STILWELL… - jmilabs.com
Objectives: To summarize the susceptibility rate (% susceptible [S]) experience for
piperacillin/tazobactam [P/T] tested against Pseudomonas aeruginosa isolates from the Asia …

Antipseudomonal activity of piperacillin/tazobactam: more than a decade of experience from the SENTRY Antimicrobial Surveillance Program (1997-2007).

RN Jones, MG Stilwell, PR Rhomberg… - … and Infectious Disease, 2009 - europepmc.org
We evaluated the susceptibility rates for piperacillin/tazobactam tested against
Pseudomonas aeruginosa isolates from the Asia-Pacific (APAC), Europe (EU), Latin …

Antipseudomonal activity of piperacillin/tazobactam: more than a decade of experience from the SENTRY Antimicrobial Surveillance Program (1997-2007).

RN Jones, MG Stilwell, PR Rhomberg, HS Sader - 2009 - cabidigitallibrary.org
We evaluated the susceptibility rates for piperacillin/tazobactam tested against
Pseudomonas aeruginosa isolates from the Asia-Pacific (APAC), Europe (EU), Latin …
[PDF] academia.edu

[PDF][PDF] Anti-Pseudomonal Activity of Piperacillin/tazobactam: More than a Decade of Experience from the SENTRY Antimicrobial Surveillance Program (1997-2007)

RN JONES, HS SADER, M STILWELL… - academia.edu
Objectives: To summarize the susceptibility rate (% susceptible [S]) experience for
piperacillin/tazobactam [P/T] tested against Pseudomonas aeruginosa isolates from the Asia …

[引用][C] Antipseudomonal activity of piperacillin/tazobactam: more than a decade of experience from the SENTRY Antimicrobial Surveillance Program (1997–2007)

RN Jones, MG Stilwell, PR Rhomberg… - … and Infectious Disease, 2009 - cir.nii.ac.jp
Antipseudomonal activity of piperacillin/tazobactam: more than a decade of experience from
the SENTRY Antimicrobial Surveillance Program (1997–2007) | CiNii Research CiNii 国立 …

Antipseudomonal activity of piperacillin/tazobactam: more than a decade of experience from the SENTRY Antimicrobial Surveillance Program (1997–2007)

RN Jones, MG Stilwell, PR Rhomberg… - Diagnostic Microbiology & …, 2009 - infona.pl
We evaluated the susceptibility rates for piperacillin/tazobactam tested against
Pseudomonas aeruginosa isolates from the Asia-Pacific (APAC), Europe (EU), Latin …

[引用][C] Antipseudomonal activity of piperacillin/tazobactam: more than a decade of experience from the SENTRY Antimicrobial Surveillance Program (1997―2007)

RN JONES, MG STILWELL… - Diagnostic …, 2009 - pascal-francis.inist.fr
Antipseudomonal activity of piperacillin/tazobactam: more than a decade of experience from the
SENTRY Antimicrobial Surveillance Program (1997―2007) CNRS Inist Pascal-Francis CNRS …

Antipseudomonal activity of piperacillin/tazobactam: more than a decade of experience from the SENTRY Antimicrobial Surveillance Program (1997-2007)

RN Jones, MG Stilwell… - Diagnostic …, 2009 - pubmed.ncbi.nlm.nih.gov
We evaluated the susceptibility rates for piperacillin/tazobactam tested against
Pseudomonas aeruginosa isolates from the Asia-Pacific (APAC), Europe (EU), Latin …

[引用][C] Antipseudomonal activity of piperacillin/tazobactam: more than a decade of experience from the SENTRY Antimicrobial Surveillance Program (1997―2007)

RN JONES, MG STILWELL, PR RHOMBERG… - … and infectious disease, 2009 - Elsevier